Skip to main content
. 2019 Aug 2;16(5):993–1003. doi: 10.5114/aoms.2019.86972

Table II.

Prevalence and characteristics of the Very Large Database of Lipids study population by HLP3 status (apoB method)

Parameter HLP3 n = 2,239 (1.74%) No HLP3 n = 126,246 (98.26%) P-value
Age, % (n): < 0.001
 18–39 11.7 (262) 15.4 (19,347)
 40–75 76.2 (1,700) 73.6 (92,689)
 > 75 12.1 (270) 11.0 (13,923)
Sex, % (n): < 0.001
 Male 27.9 (622) 45.1 (56,590)
 Female 72.1 (1,606) 54.9 (68,986)
Presence of diabetes, % (n) 17.8 (399) 20.2 (25,490) 0.006
Presence of hypertension, % (n) 25.3 (567) 25.6 (32,256) 0.808
Total cholesterol, median (IQR) 206 (177–239) 197 (168–228) < 0.001
ApoB, median (IQR) 79 (66–93) 92 (77–109) < 0.001
HDL-C, median (IQR) 67 (56–78) 52 (42–64) < 0.001
VLDL-C, median (IQR) 30 (26–40) 22 (17–29) < 0.001
VLDL3-C, median (IQR) 16 (14–22) 13 (10–16) < 0.001
RLP-C, median (IQR) 34 (27–46) 26 (20–34) < 0.001
IDL-C, median (IQR) 17 (13–25) 13 (9–19) < 0.001
Estimated LDL-C, median (IQR) 107 (85–134) 117 (94–144) < 0.001
LDL-Cr, median (IQR) 73 (48–99) 95 (73–119) < 0.001
TG, median (IQR) 161 (144–196) 109 (78–157) < 0.001

ApoB – apolipoprotein B, estimated LDL-C – low-density lipoprotein cholesterol via Martin/Hopkins equation estimation, HDL-C – high-density lipoprotein cholesterol, HLP3 – type III familial hyperlipoproteinemias, IQR – interquartile range, LDL-Cr – real low-density cholesterol, RLP-C – remnant lipoprotein cholesterol, TG – triglyceride, VLDL-C – very-low density lipoprotein cholesterol, VLDL3-C – very-low density cholesterol subfraction 3.